This webinar was previously recorded on July 20, 2021. To view a recording of the webinar, click here. To access an audio only version of this webinar, click here. CLE credit is not available for on-demand viewing.

M&A activity involving behavioral health providers continues to increase, in parallel with the expanded need for access to these services. As more reimbursement and investment dollars flow into behavioral health, treatment providers have faced new regulations and increased enforcement activity. Well-advised providers, investors and other stakeholders will need to be vigilant to avoid potential regulatory pitfalls along the way.
 
Join Polsinelli’s Behavioral Health Law Group, Jennifer Lohse, Vice-President and General Counsel of Hazelden Betty Ford Foundation and Edye Bauer, General Counsel of Discovery Behavioral Health, as they discuss how to spot some of the potential regulatory pitfalls in behavioral health M&A transactions and considerations for how to best address them.

Agenda:

•  Brief Overview of Trends in SUD and mental health M&A
•  EKRA and other fraud and abuse-related regulatory pitfalls
•  Corporate practice and scope of licensure regulatory pitfalls
•  HIPAA/privacy/42 CFR Part 2 pitfalls

Speakers: 

•  Jennifer Lohse, Vice President and General Counsel, Hazelden Betty Ford Foundation
•  Edye Bauer, General Counsel, Discovery Behavioral Health
•  Paul A. Gomez, Chair, Behavioral Health Law Group, Shareholder, Polsinelli
•  Rick Rifenbark, Shareholder, Polsinelli
•  Tani Weiner, Vice Chair, Behavioral Health Law Group, Shareholder, Polsinelli
•  Shuchi Parikh, Associate, Polsinelli